Hinge Health, Inc. (HNGE)
116.90
+1.62
(+1.41%)
USD |
NYSE |
Oct 29, 16:00
116.00
-0.90
(-0.77%)
Pre-Market: 08:50
Hinge Health Enterprise Value : 8.992B for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 8.992B |
| October 28, 2026 | 8.862B |
| October 27, 2026 | 8.751B |
| October 26, 2026 | 8.576B |
| October 23, 2026 | 8.560B |
| October 22, 2026 | 8.433B |
| October 21, 2026 | 8.599B |
| October 20, 2026 | 8.239B |
| October 19, 2026 | 7.954B |
| October 16, 2026 | 7.569B |
| October 15, 2026 | 8.034B |
| October 14, 2026 | 8.038B |
| October 13, 2026 | 8.049B |
| October 12, 2026 | 8.023B |
| October 09, 2026 | 7.869B |
| October 08, 2026 | 7.476B |
| October 07, 2026 | 7.465B |
| October 06, 2026 | 7.504B |
| October 05, 2026 | 7.504B |
| October 02, 2026 | 7.450B |
| October 01, 2026 | 7.471B |
| September 30, 2026 | 7.415B |
| September 29, 2026 | 7.252B |
| September 28, 2026 | 7.031B |
| September 25, 2026 | 7.281B |
| Date | Value |
|---|---|
| September 24, 2026 | 6.993B |
| September 23, 2026 | 7.017B |
| September 22, 2026 | 7.167B |
| September 21, 2026 | 7.191B |
| September 18, 2026 | 7.228B |
| September 17, 2026 | 7.213B |
| September 16, 2026 | 7.134B |
| September 15, 2026 | 7.026B |
| September 14, 2026 | 7.219B |
| September 11, 2026 | 6.721B |
| September 10, 2026 | 6.695B |
| September 09, 2026 | 6.940B |
| September 08, 2026 | 7.050B |
| September 04, 2026 | 7.025B |
| September 03, 2026 | 6.896B |
| September 02, 2026 | 6.983B |
| September 01, 2026 | 6.836B |
| August 31, 2026 | 7.040B |
| August 28, 2026 | 6.622B |
| August 27, 2026 | 7.063B |
| August 26, 2026 | 6.875B |
| August 25, 2026 | 6.824B |
| August 24, 2026 | 6.833B |
| August 21, 2026 | 6.708B |
| August 20, 2026 | 6.483B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| West Pharmaceutical Services, Inc. | 28.92B |
| Vivos Therapeutics, Inc. | 13.42M |
| Exlites Holdings International, Inc. | 19.82M |
| Xcelerate, Inc. | 12.35M |
| Teleflex, Inc. | 8.549B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 43.10M |
| Revenue (Quarterly) | 212.82M |
| Total Expenses (Quarterly) | 169.72M |
| EPS Diluted (Quarterly) | 0.5167 |
| Gross Profit Margin (Quarterly) | 86.44% |
| Profit Margin (Quarterly) | 20.25% |
| Earnings Yield | 1.11% |
| Operating Earnings Yield | 1.03% |
| Normalized Earnings Yield | 1.137 |